Search results for "Randomized"

showing 10 items of 2323 documents

The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes

2015

Background. Critically ill patients appear to be at high risk of developing deep vein thrombosis (DVT) and pulmonary embolism during their stay in the intensive care unit (ICU). However, little is known about the clinical course of venous thromboembolism in the ICU setting. We therefore evaluated, through a systematic review of the literature, the available data on the impact of a diagnosis of DVT on hospital and ICU stay, duration of mechanical ventilation and mortality in critically ill patients. We also tried to determine whether currently adopted prophylactic measures need to be revised and improved in the ICU setting. Materials and methods. MEDLINE and EMBASE databases were searched up…

RiskCritical IllnessIntensive Care UnitCritically ill patients; Deep vein thrombosis; Meta-analysis; Outcomes; Cohort Studies; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Pulmonary Embolism; Randomized Controlled Trials as Topic; Research Design; Respiration Artificial; Risk; Thrombophilia; Treatment Outcome; Venous Thrombosis; Critical Illness; Hematology; Immunology and AllergyReviewDeep Vein Thrombosis Critically Ill Patients outcomes metanalysisCohort StudiesDeep vein thrombosiImmunology and AllergyHumansThrombophiliaMeta-analysiVenous ThrombosiHospital MortalityOutcomeRandomized Controlled Trials as TopicVenous ThrombosisHematologyLength of StayRespiration ArtificialIntensive Care UnitsTreatment OutcomeResearch DesignCritical IllneCritically ill patientCohort StudiePulmonary EmbolismHuman
researchProduct

Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis

2012

Background Routine second-look endoscopy in modern-era peptic ulcer bleeding (PUB) remains controversial. Objective To assess the effectiveness of routine second-look endoscopy in patients with PUB exhibiting high-risk stigmata after standard medical care and endoscopic therapy. Design Comprehensive literature searches (1990-2011) were performed, seeking randomized trials comparing a routine with an as-needed second endoscopy. Main Outcome Measurements The main outcome was rebleeding. Secondary outcomes were surgery and mortality. Subanalyses assessed the influence of study quality, rebleeding definitions, endoscopic hemostasis modality, and proton pump inhibitor (PPI) therapies. Analyses w…

Riskmedicine.medical_specialtymedicine.drug_classMEDLINEProton-pump inhibitorlaw.inventionRandomized controlled trialRecurrencelawOdds RatiomedicineHumansRadiology Nuclear Medicine and imagingModels Statisticalmedicine.diagnostic_testbusiness.industryHemostasis EndoscopicGastroenterologyProton Pump InhibitorsOdds ratioConfidence intervalSurgeryEndoscopyPeptic Ulcer HemorrhageTreatment OutcomeMeta-analysisHemostasisbusinessGastrointestinal Endoscopy
researchProduct

Rivaroxaban in Peripheral Artery Disease after Revascularization

2020

Abstract Background Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and ...

RivaroxabanAspirinmedicine.medical_specialtyArterial diseasebusiness.industrymedicine.medical_treatmentGeneral MedicineDisease030204 cardiovascular system & hematologyRevascularizationlaw.invention03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled trialMulticenter studylawInternal medicineCardiologyMedicine030212 general & internal medicinebusinessmedicine.drugNew England Journal of Medicine
researchProduct

Small-diameter titanium Grade IV and titanium-zirconium implants in edentulous mandibles: three-year results from a double-blind, randomized controll…

2015

OBJECTIVE: The aim of this study was to compare crestal bone-level changes, soft tissue parameters and implant success and survival between small-diameter implants made of titanium/zirconium (TiZr) alloy or of Grade IV titanium (Ti) in edentulous mandibles restored with removable overdentures. MATERIALS AND METHODS: This was a randomized, controlled, double-blind, split-mouth multicenter clinical trial. Patients with edentulous mandibles received two Straumann bone-level implants (diameter 3.3 mm), one of Ti Grade IV (control) and one of TiZr (test), in the interforaminal region. Implants were loaded after 6-8 weeks and removable Locator-retained overdentures were placed within 2 weeks of l…

RoxolidMaleSmall diameterSLActive surfaceDentistrychemistry.chemical_elementMandibleCONVENTIONAL COMPLETE DENTURESlaw.inventionDouble blindRETROSPECTIVE EVALUATION IMPLANTDouble-Blind MethodRandomized controlled triallawMARGINAL BONE LOSSHumansJaw EdentulousMedicineMANDIBULAR 2-IMPLANT OVERDENTURES610 Medicine & healthAgedDental ImplantsTitaniumPATIENT SATISFACTIONTitanium/zirconiumSTRESS-DISTRIBUTIONbusiness.industryDental Implantation Endosseoustechnology industry and agricultureWITHIN-SUBJECT COMPARISONSSoft tissueDIFFERENT LOADING PROTOCOLSDenture Overlayequipment and suppliesTitanium zirconiumddc:617.6Treatment OutcomeDental Prosthesis DesignchemistryImplant typesedentulousFemaleZirconiumImplantFINITE-ELEMENT-ANALYSISOral SurgerybusinessDental AlloysTitaniumClinical Oral Implants Research
researchProduct

Small-diameter titanium grade IV and titanium-zirconium implants in edentulous mandibles: five-year results from a double-blind, randomized controlle…

2015

BACKGROUND The aim of this study was to compare the 5-year survival and success rates of 3.3 mm dental implants either made from titanium-zirconium (TiZr) alloy or from Grade IV titanium (Ti Grade IV) in mandibular implant-based removable overdentures. METHODS The core study had a follow-up period of 36 months and was designed as a randomized, controlled, double-blind, split-mouth multicenter clinical trial. Patients with edentulous mandibles received two Straumann Bone Level implants (diameter 3.3 mm, SLActive®), one of TiZr (test) and one of Ti Grade IV (control), in the interforaminal region. This follow-up study recruited patients from the core study and evaluated the plaque and sulcus …

RoxolidSmall diameterSplit-mouthDentistrychemistry.chemical_element610 Medicine & healthMandiblelaw.inventionTiZrDouble blindstomatognathic systemRandomized controlled trialDouble-Blind MethodlawOverdenturesAlloysMedicineHumansJaw Edentulous610 Medicine & healthGeneral DentistrySurvival rateOrthodonticsDental ImplantsTitaniumbusiness.industryDentistry(all)Ti Grade IVDental Implantation Endosseoustechnology industry and agricultureSLActiveequipment and suppliesDenture OverlayTitanium zirconiumddc:617.6stomatognathic diseaseschemistryDental Prosthesis DesignOral and maxillofacial surgeryImplantZirconiumbusinessTitaniumFollow-Up StudiesResearch Article
researchProduct

Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice.

2015

Hepatocellular carcinoma is a challenging malignancy of global importance. It is the sixth most common solid malignancy and the third leading cause of cancer-related death, worldwide. Curative treatments at early stages include liver transplantation, resection and percutaneous ablation, while transarterial chemoembolization can improve survival in patients with intermediate tumor stage. Patients with mild, related symptoms and/or macrovascular invasion or extrahepatic spread are classified under the advanced stage. The standard of care in this group is sorafenib, an inhibitor of Raf kinase and vascular endothelial growth factor receptor, whose effectiveness has been proven by 2 recent rando…

SHARPOncologyHepatocellular carcinomamedicine.medical_treatmentOLTLiver transplantationGastroenterologyLiver cirrhosilaw.inventionAntineoplastic AgentRandomized controlled triallawPractice Patterns Physicians'Randomized Controlled Trials as TopicNexavarMedicine (all)Liver NeoplasmsGastroenterologyGeneral MedicineSorafenibLocoregional therapiePercutaneous ethanol injectionLiver NeoplasmRaf kinaseHepatocellular carcinomaLiver cancerLiver cancerHumanmedicine.drugSorafenibNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularAntineoplastic AgentsMalignancyTransarterial chemoembolizationInternal medicinemedicineCarcinomaChemotherapyHumansChemoembolization Therapeuticbusiness.industryPhenylurea CompoundsRadiofrequency ablationResectionmedicine.diseaseBCLCPercutaneous ethanol injectionbusinessDigestive diseases (Basel, Switzerland)
researchProduct

Usage and Dose Response of a Mobile Acceptance and Commitment Therapy App: Secondary Analysis of the Intervention Arm of a Randomized Controlled Trial

2016

Background: Mobile phone apps offer a promising medium to deliver psychological interventions. A mobile app based on Acceptance and Commitment Therapy (ACT) was developed and studied in a randomized controlled trial (RCT). Objective: To study usage metrics of a mobile ACT intervention and dose-response relationship between usage and improvement in psychological flexibility. Methods: An RCT was conducted to investigate the effectiveness of different lifestyle interventions for overweight people with psychological stress. This paper presents a secondary analysis of the group that received an 8-week mobile ACT intervention. Most of the analyzed 74 participants were female (n=64, 86%). Their me…

SMARTPHONE APPLICATION020205 medical informaticsretrospective studyPsychological intervention02 engineering and technologyLogistic regressionAcceptance and commitment therapy3124 Neurology and psychiatrylaw.invention0302 clinical medicinePROGRAMSRandomized controlled trialInterquartile rangelaw0202 electrical engineering electronic engineering information engineeringmobiilisovelluksetWEB-BASED ACCEPTANCEMedicine030212 general & internal medicineadherencePREDICTORSmHealthApplied Psychologyta515mobile appsT58.5-58.64DEPRESSION3. Good healthHEALTHPublic aspects of medicineRA1-1270medicine.medical_specialty515 Psychologyhyväksymis- ja omistautumisterapiaSTUDENTSHealth InformaticsContext (language use)Information technology03 medical and health sciencesNursingAcceptance and Commitment TherapyOriginal Paperbusiness.industryTillämpad psykologiSMOKING-CESSATIONConfidence interval3141 Health care scienceacceptance and commitment therapyPhysical therapyATTRITIONbusiness
researchProduct

Assessment of the capacity of a pyrophosphate-based mouth rinse to inhibit the formation of supragingival dental calculus. a randomized double-blind …

2019

Background This study aimed to analyze the efficacy of an anti-calculus mouth rinse and its possible adverse effects on the mucosa and teeth. Material and Methods This randomized double-blind placebo-controlled clinical trial included 40 patients with treated and managed periodontal disease, all with a history of rapid calculus formation. Patients used a pyrophosphate-based test mouth rinse (B) or a placebo (A). A range of parameters were measured for: saliva (saliva flow, pH and chemical composition); calculus (Volpe-Manhold [V-M] index, weight, and volume); adverse effects on mucosa and teeth; and the patients’ subjective perceptive of mouth rinse efficacy. Results The test mouth rinse B …

SalivaMouthwashesPlacebolaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind Methodstomatognathic systemRandomized controlled triallawDentifriceCalculusHumansMedicineDental CalculusAdverse effectGeneral DentistryDentifricesOral Medicine and Pathologybusiness.industryResearchCalculus (dental)030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDiphosphatesstomatognathic diseasesOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASUreaUric acidSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Efficacy of chlorhexidine, hydrogen peroxide and tulsi extract mouthwash in reducing halitosis using spectrophotometric analysis : a randomized contr…

2019

Background To evaluate the efficacy of tulsi extract mouthrinse in reducing halitosis as compared to chlorhexidine and hydrogen peroxide mouthrinses using spectrophotometric analysis. Material and methods It was a parallel, single center, double blinded randomized controlled trial of 15 days duration. A total of 300 participants were screened, out of which 45 subjects those fulfilled inclusion criteria of age range 17-35 years were included in the trial. The participants were randomly provided with tulsi, hydrogen peroxide or chlorhexidine mouthwashes (control group) to use 10 ml twice daily for 15 days. Clinical measurements were taken at baseline and 15 days using arbitrary 0-5 scale for …

SalivaPlaque indexCost effectiveness0211 other engineering and technologiesDentistry02 engineering and technologylaw.invention03 medical and health scienceschemistry.chemical_compoundGingivitis0302 clinical medicineRandomized controlled triallaw021105 building & constructionMedicineHydrogen peroxideGeneral Dentistrybusiness.industryResearchChlorhexidine030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Community and Preventive DentistryGingival indexchemistryUNESCO::CIENCIAS MÉDICASmedicine.symptombusinessmedicine.drug
researchProduct

The Influence of Friction on Design of the Type of Bracket and Its Relation to OHRQoL in Patients Who Use Multi-Bracket Appliances: A Randomized Clin…

2021

Background and objectives: The aim of this study was to evaluate the influence of friction on design of the type of bracket, patients’ perception of pain and the impact on their oral health-related quality of life. Materials and Methods: A randomized clinical trial was carried out with 90 patients (62.2% women and 37.8% men) with three kinds of fixed multi-bracket appliances: Conventional (GC), fixed multi-bracket low friction (GS) and self-ligating (GA). The VAS (Visual Analogue Scale) was used to determine pain during the first seven days of treatment at different points in time. The patients were also given the OHIP-14 (Oral Health Impact Profile) questionnaire to analyse their oral heal…

Salud bucalFrictionOrthodontic BracketsVisual analogue scaleInvestigación médicaDentistryOdontologíaOral healthArticlelaw.inventionsymbols.namesakeorthodontics; pain; quality of life; low-friction brackets; oral healthQuality of lifeRandomized controlled triallawMaterials TestingOrthodontic WiresHumansOrthodontic Appliance DesignMedicineIn patientpainlcsh:R5-920business.industryBracketAnova testGeneral Medicinelow-friction bracketsBonferroni correctionquality of lifesymbolsoral healthbusinesslcsh:Medicine (General)orthodonticsSoportes ortodóncicos
researchProduct